Prognostic factors in second-line targeted therapy for metastatic clear-cell renal cell carcinoma after progression on an anti-vascular endothelial growth factor receptor tyrosine kinase inhibitor.
| Image |  |
|---|---|
| Description | scientific article published on 23 October 2015 |
| Author/s |
author: Steven Joniau Philip R. Debruyne Raymond Oyen Benoit Beuselinck |
| Publication date | October 23, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |